Oculogica Adds to IP Portfolio with Patent for Assessment of Impairment Due to Cannabis
Oculogica’s patent enables expansion of its eye-tracking based technology to fulfill an unmet need in cannabis impairment detection
Oculogica Receives Department of Defense Grant to Develop Wearable Concussion Diagnostic with Pre-eminent Partners
Keller Army Hospital at West Point, Children’s Hospital of Philadelphia, University of Wisconsin-Green Bay and AdHawk Microsystems will work with Oculogica to develop the wearable diagnostic
Australia’s TGA Grants Approval to First Objective Concussion Diagnostic
Oculogica, a medical device company and leader in concussion diagnosis and categorization, announced today the Therapeutic Goods Administration (TGA) of Australia granted approval to its EyeBOX technology. The test is for both pediatrics and adults. The technology is also patent protected in Australia.
Oculogica Adds to IP Portfolio with Patent for Glaucoma
Oculogica, the leader in non-invasive assessment of concussion, announces today the granting of U.S. Patent No. 10,863,902 by the U.S. Patent and Trademark Office. This patent protects Oculogica’s method and system for assessing glaucoma in a patient using a noninvasive eye tracking system.
Oculogica’s Drs. Rosina and Uzma Samadani Named in Fast Company’s Annual List of the Most Creative People in Business
Oculogica Founder, Dr. Uzma Samadani and CEO, Dr. Rosina Samadani, join the 11th annual list of women and men from such companies as Netflix, Google, and Patagonia, as well as institutions such as Johns Hopkins University and the ACLU of Massachusetts.
These sisters invented a better way to diagnose concussions by tracking eye movement
Last year, the FDA granted authorization for commercial use of the first tool that provides an objective diagnosis of concussions. Called EyeBox, it was developed by sisters Uzma and Rosina Samadani.
EyeBOX Featured in Weekly Interview with The Daily Show’s Trevor Noah & Microsoft President Brad Smith
Watch our EyeBOX technology featured in Trevor Noah’s and Microsoft President Brad Smith’s discussion with Green Bay Packers President & CEO Mark Murphy.
Midwest Orthopaedics at Rush Acquires New Eye Tracking Technology to Better Assess Concussion
Midwest Orthopaedics at Rush (MOR) is the first in Illinois to offer a new eye-tracking technology to more quickly identify a patient with ocular changes after a potential concussion or traumatic brain injury.
TitletownTech leads $8 million round of funding for Oculogica
TitletownTech today announced it has invested in Oculogica, an innovative digital health company, by leading an $8 million round of funding that recently closed.
Their device promises faster and more accurate concussion assessments. A venture fund started by the Green Bay Packers took notice.
A venture fund led by the Green Bay Packers and Microsoft has invested in a new technology that promises to provide a major advance in the diagnosis of concussions.